Broncus Medical Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
208
- Stock Symbol
-
02216
- Investments
-
3
- Share Price
-
$0.24
- (As of Tuesday Closing)
Broncus Medical General Information
Description
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD.
Contact Information
Website
www.broncus.comCorporate Office
- 125 Nicholson Lane
- San Jose, CA 95134
- United States
Corporate Office
- 125 Nicholson Lane
- San Jose, CA 95134
- United States
Broncus Medical Stock Performance
As of 08-Jul-2025, Broncus Medical’s stock price is $0.24. Its current market cap is $125M with 526M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.24 | $0.25 | $0.06 - $0.37 | $125M | 526M | 6.17M | -$0.03 |
Broncus Medical Financials Summary
As of 31-Dec-2024, Broncus Medical has a trailing 12-month revenue of $8.13M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | (105,733) | (105,733) | (117,531) | (60,394) |
| Revenue | 8,131 | 8,131 | 10,255 | 9,413 |
| EBITDA | (18,539) | (18,539) | (31,101) | (27,715) |
| Net Income | (15,303) | (15,303) | (28,091) | (28,036) |
| Total Assets | 175,895 | 175,895 | 195,805 | 221,942 |
| Total Debt | 318 | 318 | 2,355 | 1,471 |
Broncus Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Broncus Medical Comparisons
Industry
Financing
Details
Broncus Medical Competitors (6)
One of Broncus Medical’s 6 competitors is Pulmonx, a Formerly VC-backed company based in Redwood City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pulmonx | Formerly VC-backed | Redwood City, CA | ||||
| Sanovas | Formerly VC-backed | Petaluma, CA | ||||
| KARL STORZ | Corporation | Tuttlingen, Germany | ||||
| Epigenomics | Formerly VC-backed | Berlin, Germany | ||||
| Veran Medical Technologies | Formerly VC-backed | Saint Louis, MO |
Broncus Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Broncus Medical Patents
Broncus Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240260945-A1 | Four-dimensional lung ultrasound imaging for image-guided interventional procedures | Pending | 03-Feb-2023 | ||
| US-20240206974-A1 | Transthoracic route planning system and method | Pending | 23-Dec-2022 | ||
| EP-4577140-A1 | Intraprocedure 2d to 3d registration adjustment method and system | Pending | 22-Aug-2022 | ||
| US-20240070933-A1 | Intraprocedure 2d to 3d registration adjustment method and system | Pending | 22-Aug-2022 | ||
| US-20230143522-A1 | Surgical assistant system based on image data of the operative field | Pending | 05-Nov-2021 | A61B34/20 |
Broncus Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Broncus Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Broncus Medical Acquisitions (3)
Broncus Medical’s most recent deal was a Merger/Acquisition with Hangzhou Jingliang for . The deal was made on 23-Nov-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hangzhou Jingliang | 23-Nov-2023 | Merger/Acquisition | Other Devices and Supplies | ||
| Fibernova Holding | 08-Sep-2023 | Merger/Acquisition | Diagnostic Equipment | ||
| Uptake Medical | 31-Aug-2016 | Merger/Acquisition | Therapeutic Devices |
Broncus Medical Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Uptake Medical | San Jose, CA | 2004 |
Broncus Medical FAQs
-
When was Broncus Medical founded?
Broncus Medical was founded in 1997.
-
Where is Broncus Medical headquartered?
Broncus Medical is headquartered in San Jose, CA.
-
What is the size of Broncus Medical?
Broncus Medical has 208 total employees.
-
What industry is Broncus Medical in?
Broncus Medical’s primary industry is Diagnostic Equipment.
-
Is Broncus Medical a private or public company?
Broncus Medical is a Public company.
-
What is Broncus Medical’s stock symbol?
The ticker symbol for Broncus Medical is 02216.
-
What is the current stock price of Broncus Medical?
As of 08-Jul-2025 the stock price of Broncus Medical is $0.24.
-
What is the current market cap of Broncus Medical?
The current market capitalization of Broncus Medical is $125M.
-
What is Broncus Medical’s current revenue?
The trailing twelve month revenue for Broncus Medical is $8.13M.
-
Who are Broncus Medical’s competitors?
Pulmonx, Sanovas, KARL STORZ, Epigenomics, and Veran Medical Technologies are some of the 6 competitors of Broncus Medical.
-
What is Broncus Medical’s annual earnings per share (EPS)?
Broncus Medical’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
